Top Markets
Coin of the day
National Graphite Corp. National Graphite Corp.

National Graphite Corp.

NGRC
Rank in Stocks #35948
National Graphite Corp. (NGRC), operating through its subsidiary Biotech... National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.
Share Price
$0.021
Last synced: 2026-08-13
Market Cap
$3.24M
Change (1 day)
0.00%
Change (1 year)
-46.15%
Country
US
Trade National Graphite Corp. (NGRC)
Stock price history for National Graphite Corp. (NGRC)
Highest end of day price: $0.02 on 2026-08-01

Lowest end of day price: $13.33 on 2012-08-01
Stock price history of National Graphite Corp. from 2012 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 43.77%
2025 -40.77%
2024 -34.87%
2023 -38.75%
2022 -23.26%
2021 160.93%
2020 52.70%
2019 -17.60%
2018 -16.56%
2017 -18.16%
2016 -36.30%
2015 -74.52%
2014 -34.53%
2013 -95.88%
2012 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$300.00 0.00%
US
$2.65 0.00%
US
$22.70 0.00%
CN
$7.39 0.00%
US
$49.95 0.00%
US